EZZ Life Science Holdings Limited (EZZ.AX)
AUD 1.45
(-0.68%)
AUD 1.45
(-0.68%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 10.37 Million AUD | 103.72% |
| 2023 | 5.09 Million AUD | 152.15% |
| 2022 | 1.9 Million AUD | -33.78% |
| 2021 | 2.76 Million AUD | 76.64% |
| 2020 | 2.3 Million AUD | 37.74% |
| 2019 | 1.18 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 753.12 Thousand AUD | -76.86% |
| 2024 Q2 | 1.68 Million AUD | 129.93% |
| 2024 Q4 | 8.42 Million AUD | 0.0% |
| 2024 FY | - AUD | 110.7% |
| 2023 Q2 | 1.81 Million AUD | 104.84% |
| 2023 Q3 | 1.45 Million AUD | -19.72% |
| 2023 Q1 | 884.51 Thousand AUD | -47.68% |
| 2023 FY | - AUD | 152.15% |
| 2023 Q4 | 2.98 Million AUD | 105.25% |
| 2022 Q1 | 62.44 Thousand AUD | -94.25% |
| 2022 FY | - AUD | -33.78% |
| 2022 Q4 | 1.69 Million AUD | 101.96% |
| 2022 Q3 | 837.05 Thousand AUD | 1092.39% |
| 2022 Q2 | 70.2 Thousand AUD | 12.42% |
| 2021 FY | - AUD | 76.64% |
| 2021 Q2 | 1.61 Million AUD | 90.56% |
| 2021 Q3 | 536 Thousand AUD | -66.77% |
| 2021 Q4 | 1.08 Million AUD | 102.49% |
| 2021 Q1 | 846.47 Thousand AUD | -16.68% |
| 2020 Q3 | 825.44 Thousand AUD | 35.2% |
| 2020 Q4 | 1.01 Million AUD | 23.07% |
| 2020 Q2 | 610.55 Thousand AUD | 100.0% |
| 2020 Q1 | 305.27 Thousand AUD | 0.0% |
| 2020 FY | - AUD | 37.74% |
| 2019 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AdAlta Limited | -5.3 Million AUD | 295.664% |
| Biome Australia Limited | -1.57 Million AUD | 757.403% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 122.865% |
| Biotron Limited | -5.04 Million AUD | 305.86% |
| Acrux Limited | -7.93 Million AUD | 230.822% |
| Alterity Therapeutics Limited | -19.57 Million AUD | 153.013% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | 174.54% |
| BTC Health Limited | 1.05 Million AUD | -883.189% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | 191.82% |
| CSL Limited | 4.73 Billion AUD | 99.781% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 123.239% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 79.994% |
| Immutep Limited | -42.87 Million AUD | 124.199% |
| Memphasys Limited | -3.3 Million AUD | 413.674% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 94.793% |
| Noxopharm Limited | -5.94 Million AUD | 274.51% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 244.39% |
| Race Oncology Limited | -14.2 Million AUD | 173.049% |
| Starpharma Holdings Limited | -12.57 Million AUD | 182.496% |
| Tissue Repair Ltd | -5.77 Million AUD | 279.662% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | 812.276% |
| Bio-Gene Technology Limited | -2.97 Million AUD | 448.757% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 128.472% |
| Patrys Limited | -3.49 Million AUD | 397.108% |
| Orthocell Limited | -11.68 Million AUD | 188.823% |
| Imugene Limited | -147.97 Million AUD | 107.012% |
| PYC Therapeutics Limited | -38.11 Million AUD | 127.22% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | 231.546% |
| Cynata Therapeutics Limited | -9.95 Million AUD | 204.274% |
| Arovella Therapeutics Limited | -8.83 Million AUD | 217.46% |
| Nanollose Limited | -1.14 Million AUD | 1003.864% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | 1540.155% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | 677.607% |
| Amplia Therapeutics Limited | -4.55 Million AUD | 327.552% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | 468.17% |
| Nyrada Inc. | -4.59 Million AUD | 325.74% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 54.822% |
| Dimerix Limited | -24.95 Million AUD | 141.571% |
| PharmAust Limited | -9.45 Million AUD | 209.773% |
| Hexima Limited | -995.54 Thousand AUD | 1142.192% |
| AnteoTech Limited | -11.57 Million AUD | 189.668% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 116.076% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | 148.588% |
| Avecho Biotechnology Limited | -3.24 Million AUD | 419.983% |
| Actinogen Medical Limited | -12.92 Million AUD | 180.298% |
| Immuron Limited | -6.19 Million AUD | 267.553% |
| Argenica Therapeutics Limited | -1.89 Million AUD | 646.771% |